home / stock / hltrf / hltrf short
Short Information | HLS Therapeutics Inc (OTCMKTS:HLTRF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 16,903 |
Total Actual Volume | 70,201 |
Short Trends | |
---|---|
Cover Days | 8 |
Short Days | 12 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 845 |
Average Short Percentage | 60.35% |
Is there a HLTRF Short Squeeze or Breakout about to happen?
See the HLTRF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-09-2024 | $3.85 | $3.85 | $3.85 | $3.85 | 2,000 | 1,103 | 55.15% |
04-08-2024 | $3.95 | $4 | $4 | $3.95 | 1,300 | 1,100 | 84.62% |
01-29-2024 | $3.19 | $3.19 | $3.19 | $3.19 | 100 | 100 | 100% |
12-28-2023 | $3.84 | $3.84 | $3.84 | $3.84 | 300 | 300 | 100% |
12-20-2023 | $2.73 | $2.73 | $2.73 | $2.73 | 1,500 | 200 | 13.33% |
11-20-2023 | $2.7 | $2.7433 | $2.75 | $2.7 | 1,500 | 1,500 | 100% |
11-17-2023 | $2.78 | $2.765 | $2.81 | $2.765 | 2,500 | 700 | 28% |
11-16-2023 | $2.6 | $2.6 | $2.6 | $2.6 | 5,200 | 900 | 17.31% |
11-15-2023 | $2.88 | $2.94 | $2.94 | $2.88 | 1,000 | 1,000 | 100% |
11-14-2023 | $2.92 | $2.92 | $2.92 | $2.92 | 100 | 100 | 100% |
11-13-2023 | $2.92 | $2.92 | $2.92 | $2.92 | 200 | 200 | 100% |
10-30-2023 | $3.7488 | $3.75 | $3.75 | $3.7343 | 8,701 | 1,500 | 17.24% |
09-20-2023 | $3.84 | $3.84 | $3.84 | $3.84 | 3,700 | 100 | 2.7% |
08-29-2023 | $3.2136 | $3.3 | $3.3 | $3.2 | 4,800 | 4,400 | 91.67% |
08-24-2023 | $3.3 | $3.3 | $3.3 | $3.3 | 100 | 100 | 100% |
08-15-2023 | $3.69 | $3.69 | $3.69 | $3.69 | 1,100 | 900 | 81.82% |
08-03-2023 | $4.55 | $4.55 | $4.55 | $4.55 | 2,900 | 100 | 3.45% |
07-24-2023 | $4.75 | $4.75 | $4.75 | $4.75 | 7,800 | 200 | 2.56% |
07-18-2023 | $4.94 | $4.94 | $4.94 | $4.94 | 100 | 100 | 100% |
07-05-2023 | $4.75 | $4.6822 | $4.75 | $4.6822 | 25,300 | 2,300 | 9.09% |
News, Short Squeeze, Breakout and More Instantly...
HLS Therapeutics Inc Company Name:
HLTRF Stock Symbol:
OTCMKTS Market:
HLS Therapeutics Announces First Quarter Fiscal 2021 Financial Results Canada NewsWire Q1 2021 revenue of $14.3 million , Adjusted EBITDA of $6.7 million and cash from operations of $7.2 million , up $0.4 million , $0.6 million and $1.8 million ...
HLS Therapeutics to Host Q1 2021 Financial Results Conference Call Canada NewsWire TORONTO , April 22, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 2021 financial results on Thursday, May 6, 2021 ...
HLS Therapeutics Announces Participation in Upcoming Conferences Canada NewsWire TORONTO , April 15, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a specialty pharmaceutical company focused on central nervous system and cardiovascular ma...